Skip to main content
Defiance International

A novel selective VPAC2 agonist peptide-conjugated chitosan modified selenium nanoparticles with enhanced anti-type 2 diabetes synergy effects.

Study record. International journal of nanomedicine, 2017. No summary is published for it.

  • 2017

Authorship

No summary is published for this record. No date is promised for one.

Verification: PMID confirmed at PubMed

This study and its findings belong to the authors cited. Defiance International, a supplier of chemical sequences for research use, keeps this record and makes no claim from its findings.

Verify a lot

PMID confirmed at PubMed

Open declared source

Key facts

Design
Design subtype not established
System
Not reported
Scale
Not reported
Comparator
None reported
Journal
International journal of nanomedicine
Year
2017
PMID
28356733
Verification
PMID confirmed at PubMed The PMID shown was confirmed at PubMed on 2026-09-14: PubMed held a record under this identifier. This check confirms the identifier only, not the study type, the findings, or any relevance to a chemical sequence. It is held as a citation, not evidence. No tier is an endorsement, an evidence-strength rating, or independent replication, and none establishes efficacy, safety, or suitability.
Full-text availability
Bibliographic details only

Technical summary

No technical summary is published for this record.

Limitations and uncertainty

Not reported in the declared source.

Cite

Cite the study

A novel selective VPAC2 agonist peptide-conjugated chitosan modified selenium nanoparticles with enhanced anti-type 2 diabetes synergy effects.
Zhao SJ, Wang DH, Li YW, Han L, Xiao X, Ma M, Wan DC, Hong A, Ma Y. International journal of nanomedicine. 2017. PMID 28356733. DOI 10.2147/ijn.s130566

The study and its abstract belong to their authors and publisher. Cite them for anything the study found.

Report an error

If a sentence on this record does not match the abstract, tell us which one. A report starts an automatic re-check by machine. No person reads the record first.

The form takes a sentence and your note. It asks for no name and no address, and we store neither. Do not put personal details in the note.

The report form runs in the interactive page. Open this record with scripts enabled to send a report.

Corrections on this record

No correction has been recorded for this record.

Method sheet

No machine-drafted summary is published on this record. Any section shown is the abstract’s own sentence, printed as issued.